202 related articles for article (PubMed ID: 23624918)
21. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.
Reilly KM; Loisel DA; Bronson RT; McLaughlin ME; Jacks T
Nat Genet; 2000 Sep; 26(1):109-13. PubMed ID: 10973261
[TBL] [Abstract][Full Text] [Related]
22. MAPK pathway activation and the origins of pediatric low-grade astrocytomas.
Tatevossian RG; Lawson AR; Forshew T; Hindley GF; Ellison DW; Sheer D
J Cell Physiol; 2010 Mar; 222(3):509-14. PubMed ID: 19937730
[TBL] [Abstract][Full Text] [Related]
23. Pilocytic astrocytomas.
Bornhorst M; Frappaz D; Packer RJ
Handb Clin Neurol; 2016; 134():329-44. PubMed ID: 26948364
[TBL] [Abstract][Full Text] [Related]
24. SNP-based detection of allelic imbalance: A novel approach for identifying KIAA1549-BRAF fusion in pilocytic astrocytoma using DNA sequencing.
Bobach IS; Stougaard M
Exp Mol Pathol; 2021 Jun; 120():104621. PubMed ID: 33626378
[TBL] [Abstract][Full Text] [Related]
25. [OMICS and biomarkers of glial tumors].
Idbaih A
Rev Neurol (Paris); 2011 Oct; 167(10):691-8. PubMed ID: 21889780
[TBL] [Abstract][Full Text] [Related]
26. MAPK pathway activation through BRAF gene fusion in pilocytic astrocytomas; a novel oncogenic fusion gene with diagnostic, prognostic, and therapeutic potential.
Jeuken JW; Wesseling P
J Pathol; 2010 Dec; 222(4):324-8. PubMed ID: 20976706
[TBL] [Abstract][Full Text] [Related]
27. Neurofibromin in the brain.
Gutmann DH
J Child Neurol; 2002 Aug; 17(8):592-601; discussion 602-4, 646-51. PubMed ID: 12403558
[TBL] [Abstract][Full Text] [Related]
28. Rare adult pilocytic astrocytoma of the septum pellucidum with novel RIN2::BRAF fusion.
Liu X; Dai X; Dai C; Zhu Q; Chen A; Chen Y; Chen N; Chen P; Rong R; Shi C; Xiao S; Dong J
Virchows Arch; 2023 Feb; 482(2):445-450. PubMed ID: 36520196
[TBL] [Abstract][Full Text] [Related]
29. Whole Chromosome 7 Gain Predicts Higher Risk of Recurrence in Pediatric Pilocytic Astrocytomas Independently From KIAA1549-BRAF Fusion Status.
Roth JJ; Fierst TM; Waanders AJ; Yimei L; Biegel JA; Santi M
J Neuropathol Exp Neurol; 2016 Apr; 75(4):306-15. PubMed ID: 26945035
[TBL] [Abstract][Full Text] [Related]
30. Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas.
Gutmann DH; Donahoe J; Brown T; James CD; Perry A
Neuropathol Appl Neurobiol; 2000 Aug; 26(4):361-7. PubMed ID: 10931370
[TBL] [Abstract][Full Text] [Related]
31. The ecology of brain tumors: lessons learned from neurofibromatosis-1.
Pong WW; Gutmann DH
Oncogene; 2011 Mar; 30(10):1135-46. PubMed ID: 21076468
[TBL] [Abstract][Full Text] [Related]
32. Increased neurofibromatosis 1 gene expression in astrocytic tumors: positive regulation by p21-ras.
Gutmann DH; Giordano MJ; Mahadeo DK; Lau N; Silbergeld D; Guha A
Oncogene; 1996 May; 12(10):2121-7. PubMed ID: 8668337
[TBL] [Abstract][Full Text] [Related]
33. No aberrant methylation of neurofibromatosis 1 gene (NF1) promoter in pilocytic astrocytoma in childhood.
Ebinger M; Senf L; Wachowski O; Scheurlen W
Pediatr Hematol Oncol; 2005; 22(1):83-7. PubMed ID: 15770836
[TBL] [Abstract][Full Text] [Related]
34. Conditional KIAA1549:BRAF mice reveal brain region- and cell type-specific effects.
Kaul A; Chen YH; Emnett RJ; Gianino SM; Gutmann DH
Genesis; 2013 Oct; 51(10):708-16. PubMed ID: 23893969
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA profile of pediatric pilocytic astrocytomas identifies two tumor-specific signatures when compared to non-neoplastic white matter.
Darrigo Júnior LG; Lira RCP; Fedatto PF; Marco Antonio DS; Valera ET; Aguiar S; Yunes JA; Brandalise SR; Neder L; Saggioro FP; Becker AP; de Oliveira RS; Machado HR; Panepucci RA; Tone LG; Scrideli CA
J Neurooncol; 2019 Jan; 141(2):373-382. PubMed ID: 30570705
[TBL] [Abstract][Full Text] [Related]
36. Outcome analysis of childhood pilocytic astrocytomas: a retrospective study of 148 cases at a single institution.
Colin C; Padovani L; Chappé C; Mercurio S; Scavarda D; Loundou A; Frassineti F; André N; Bouvier C; Korshunov A; Lena G; Figarella-Branger D
Neuropathol Appl Neurobiol; 2013 Oct; 39(6):693-705. PubMed ID: 23278243
[TBL] [Abstract][Full Text] [Related]
37. Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.
Hargrave D
Br J Neurosurg; 2009 Aug; 23(4):351-63. PubMed ID: 19637006
[TBL] [Abstract][Full Text] [Related]
38. Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma.
Korshunov A; Meyer J; Capper D; Christians A; Remke M; Witt H; Pfister S; von Deimling A; Hartmann C
Acta Neuropathol; 2009 Sep; 118(3):401-5. PubMed ID: 19543740
[TBL] [Abstract][Full Text] [Related]
39. NF1 mutation drives neuronal activity-dependent initiation of optic glioma.
Pan Y; Hysinger JD; Barron T; Schindler NF; Cobb O; Guo X; Yalçın B; Anastasaki C; Mulinyawe SB; Ponnuswami A; Scheaffer S; Ma Y; Chang KC; Xia X; Toonen JA; Lennon JJ; Gibson EM; Huguenard JR; Liau LM; Goldberg JL; Monje M; Gutmann DH
Nature; 2021 Jun; 594(7862):277-282. PubMed ID: 34040258
[TBL] [Abstract][Full Text] [Related]
40. Loss of NF1 alleles distinguish sporadic from NF1-associated pilocytic astrocytomas.
Kluwe L; Hagel C; Tatagiba M; Thomas S; Stavrou D; Ostertag H; von Deimling A; Mautner VF
J Neuropathol Exp Neurol; 2001 Sep; 60(9):917-20. PubMed ID: 11556548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
